AFT expands European business development team

24 September 2021 - Deborah Wilkes


New Zealand’s AFT Pharmaceuticals has expanded its European business development team as it seeks to overcome the barriers to international business travel associated with the COVID-19 pandemic. In a separate development, the company has gained authorisations for its Maxigesic analgesic in Chile, Panama, Peru and South Korea.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: